Introduction
============

Iron and calcium ions are both essential for maintaining normal brain function. Iron is required for oxidative phosphorylation, Krebs cycle, iron--sulfur cluster and heme synthesis, synaptic plasticity, and the development of cognitive functions ([@B153]; [@B19]; [@B87];[@B211]; [@B239]; [@B88]; [@B139]; [@B144]; [@B130]; [@B176]), while increases in cytoplasmic calcium concentration known as calcium signals mediate the secretion of neurotransmitters, synaptic plasticity, and axonal growth ([@B14]). Moreover, nuclear calcium signals command the expression of neuronal genes involved in learning and memory processes ([@B8]).

Recent studies have revealed that cellular iron stimulates neuronal calcium signaling, leading to downstream activation of kinase cascades engaged in synaptic plasticity, a neuronal response associated to memory and learning ([@B87]; [@B85]; [@B139]). The relationship between calcium and iron is Janus-faced, however. Dysregulation of iron levels induces calcium dyshomeostasis and abnormal calcium signaling, whereas increased calcium levels enhance redox-active iron levels; neurodegenerative conditions exhibit both types of dysregulation. Thus, current evidence indicates that increased intracellular calcium and aberrant calcium signaling occur in neurodegenerative disorders that include Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS) (reviewed in [@B162]). Similarly, disruption of neuronal iron homeostasis linked to iron accumulation is a common feature in a plethora of neurodegenerative diseases, which included and other parkinsonisms ([@B112]), AD ([@B30]), Friedrich's ataxia, pantothenate kinase-associated neurodegeneration ([@B206]), and other neuronal pathologies that entail brain iron accumulation ([@B222]).

Here, we will review the evidence that points to a rarely acknowledged relationship between iron homeostasis and calcium homeostasis and signaling, in which dysregulation of one of these processes results in dysregulation of the other, generating a vicious cycle that ends up in neuronal death. The multiple cell-damaging responses generated by the unregulated iron/calcium self-feeding cycle, such as excitotoxicity, free radical-mediated lipid peroxidation, and the oxidative modification of crucial components of iron and calcium homeostasis and signaling, including the iron transporter DMT1, plasma membrane and intracellular calcium channels and pumps will be presented. This review article concludes with a discussion of how dysregulation of calcium homeostasis and signaling contributes to the generation of neurodegenerative diseases with an iron accumulation component, focusing in particular on AD and PD.

Iron Homeostasis in Neuronal Cells
==================================

Through the Fenton reaction, redox-active iron is a net producer of the hydroxyl radical, the most reactive radical species in nature ([@B46]). In a reductive environment, such as the intracellular milieu, through redox cycling redox-active iron promotes the production of hydroxyl radicals at the expense of O~2~ and GSH consumption ([@B152]). Consequently, under physiological conditions, redox-active iron levels that conform the labile iron pool are very tightly regulated to a cytosolic concentration of 0.5--1.5 μM, which comprises \<5% of total intracellular iron ([@B32]). In mammals, cellular iron levels are maintained by transcriptional, translational, and vesicular flux mechanisms ([@B149]). The iron regulatory protein (IRPs: IRP1 and IRP2)/iron-responsive element (IRE) is the best-characterized system that regulates at the translation level the expression of iron homeostasis proteins. These proteins include the transferrin receptor 1 (TfR1, involved in iron uptake), the divalent metal transporter 1 (DMT1, involved in iron uptake), ferroportin 1 (FPN1), involved in iron efflux from cells), and ferritin (involved in iron storage) ([@B223]). The IRP/IRE is a plentiful-oriented system, since it is activated under low iron conditions to ensure an adequate supply of iron for cellular processes. Of note, the IRE--IRP regulatory system is not only regulated by cellular iron status but it is also regulated by reactive oxygen species (ROS), whereby cells elicit a defense mechanism against iron toxicity and iron-catalyzed oxidative stress ([@B175]).

The iron uptake protein DMT1 (SLC11A2) is a crucial component of cell iron homeostasis. *SLC11A2* transcription generates four alternatively spliced mRNAs that differ at their 5′-untranslated region (coding for the DMT1 isoforms 1A and 1B) and at its 3′-untranslated region (coding for isoforms +IRE and --IRE) ([@B61]). Thus, the expression of the 1A and 1B isoforms of DMT1 is subjected to differential transcriptional regulation.

The Crucial Relationship Between Iron and the Hypoxia-Inducible Transcription Factor (HIF)
==========================================================================================

At the systemic level, the hypoxia-inducible transcription factor (HIF) transcription factor family coordinates the cellular response to low oxygen levels by regulating the expression of a large array of target genes during hypoxia, which results in adaptive changes in the hematopoietic, cardiovascular, and respiratory systems ([@B195]; [@B134]). The HIF-1 is kept at basal levels by HIF prolyl hydroxylase domain (PHD) enzymes; prolyl-hydroxylation of HIF-1 via PHD signals for its degradation via the ubiquitin-proteasome system ([@B28]; [@B146]; [@B229]). The PHD enzymes are both oxygen- and iron-dependent; thus, hypoxia and iron chelation results in decreased PHD activity and increased HIF-1α activity ([@B83]; [@B147]; [@B55]).

In recent years, a series of iron chelating agents that exert neuroprotective effects have been developed ([@B150]). In particular, M30, which is an 8-hydroxyquinoline-based iron chelator developed by the group of Moussa Youdim at Technion-Israel Institute of Technology ([@B221]), stabilizes HIF-1α, most probably by inactivating HIF-1α PHD. In the brain, HIF-1α stabilization by M30 leads to the expression of a broad number of neuroprotective-adaptive mechanisms and pro-survival signaling pathways ([@B105]). Real-time RT-PCR revealed that M30 differentially induces the expression of a variety of cellular components, including vascular endothelial growth factor, erythropoietin, enolase-1, TfR1, heme oxygenase-1, inducible nitric oxide synthase (iNOS), glucose transporter 1, brain-derived neurotrophic factor (BDNF), glial cell-derived neurotrophic factor, and the antioxidant enzymes catalase, superoxide dismutase-1, and glutathione peroxidase ([@B106]). Further reports have supported the role of iron chelators in inducing neuronal survival pathways ([@B129]; [@B73], [@B72]; [@B227]). It follows that the capacity of iron chelators to induce HIF-1α-mediated neuroprotection adds to the recognized neuroprotective effects of iron chelators, through their ability to prevent hydroxyl radical production via the Fenton reaction. A tempering note comes from the report that treatment of human skin cells with the iron chelator *N*-(2-hydroxybenzyl)-[L]{.smallcaps}-serine (HBSer) does not induce HIF-1α activation, as opposed to desferrioxamine (DFO) and salicylaldehyde isonicotinoyl hydrazone (SIH) used as positive controls ([@B42]). The authors conjectured that the lack of HIF-1α activation by HBSer might be related to its lower affinity for iron as compared to DFO and SIH. Of relevance to the theme of this review, however, is the fact that the transcription factor HIF-1α activates the expression of several genes associated with iron homeostasis ([@B110]), which in non-excitable cells results in an increase in cellular iron content ([@B174]).

Increased Reactive Oxygen/Nitrogen Species Generation Induces Iron Dyshomeostasis
=================================================================================

A significant number of studies have shown that physiological levels of ROS and reactive nitrogen species (RNS) act as signaling molecules in a variety of biological responses ([@B187]; [@B175]; [@B7]; [@B118]; [@B133]; [@B148]). The brain is an organ highly susceptible to oxidative stress ([@B41]). Hence, neuronal cells have to maintain physiological levels of ROS and RNS to avoid oxidative or nitrosative stress, which arises when excessive ROS/RNS production overcomes the cellular antioxidant systems, which by affecting the redox environment favors excitotoxicity. Henceforth, we will use the broad term oxidative stress to refer to both oxidative and nitrosative stress. Oxidative stress perturbs the function of many cellular processes; it causes glutathione deficiency ([@B225]) and promotes cell death by inducing mitochondrial depolarization, membrane lipid peroxidation, and DNA damage, among other harmful effects. To counteract the damaging effects of excess ROS/RNS ([@B54]; [@B77]; [@B135]), cells make use of enzymatic and non-enzymatic defense mechanisms, some of which engage calcium signals ([@B68]). Depending on the extent and persistence of the cellular damage, oxidative stress may play a key role as a causative agent of neurodegenerative disease emergence and or progression.

Iron uptake into primary hippocampal neurons stimulates ROS generation ([@B139]), and decreases the redox potential established by the intracellular levels of oxidized and reduced glutathione in neuroblastoma cells ([@B151]). The relationship between increased redox-active iron and increased oxidative stress is well accepted ([@B152]). Similarly, in cellular models convincing evidence points to a link between increased oxidative tone and iron accumulation. Initial observations indicated that hydrogen peroxide activates IRP1 ([@B125]; [@B157]; [@B80]; [@B33]; [@B136]), and that this activation results in increased cellular iron uptake mediated by increased translation of TfR1 and decreased ferritin synthesis ([@B33]; [@B203]). A subsequent study reported that, besides activation of IRP1, exposure of SH-SY5Y cells to H~2~O~2~ results in the degradation of the exo-transporter FPN1, which coupled to a decrease in ferritin translation leads to a time-dependent increase in the cellular labile iron pool ([@B48]), with the ensuing generation of oxidative damage through the production of hydroxyl radicals by the Fenton reaction. In animal models, evidence linking increased ROS as a cause, and iron homeostasis loss as an effect, is still lacking. An early report indicated that vitamin A deficiency results in increased hepcidin mRNA expression and increased iron spleen concentrations, accompanied by increased protein oxidation. These results suggest that vitamin A protects the liver against protein oxidation by maintaining iron homeostasis ([@B6]). In a mouse model of experimentally induced hemolysis, excess heme increases intracellular ROS production, which signals for the induction of the unique iron exporter ferroportin, resulting in iron export from macrophages ([@B93]; [@B124]). Of note, decreasing ROS levels by treatment with the antioxidant N-acetylcysteine prevents ferroportin induction and normalizes intracellular iron levels in a mice model of experimentally induced hemolysis ([@B208]). In a separate study using the APPswe/PS1ΔE9 AD mice model, administration for 3 months of antioxidants of plant origin decreased iron levels and malondialdehyde content and increased antioxidant defenses ([@B238]). Overall, these results are consistent with the notion that oxidative stress dysregulates iron homeostasis both in cellular and animal models.

Nitric oxide also modifies IRP1 activity; it increases IRP1 binding to IRE and the increase IRE binding activity of IRP1 is coincident with inhibited ferritin synthesis and increased TfR1 mRNA levels ([@B169]). Nitric oxide activates IRP1 directly by destabilizing the 4Fe-4S cluster of IRP1 ([@B53]; [@B198]), and may activate IRP1 indirectly by mobilizing intracellular Fe, thus decreasing the intracellular labile iron pool and activating IRP1 ([@B158]; [@B220]).

Altogether, these studies point to a robust association between increased ROS, nitric oxide, and increased levels of redox-active iron, which in turn mediate oxidative damage to lipids, protein, and nucleic acids. Yet, a recent study showed that in cultured macrophages, the labile iron pool apparently attenuates peroxynitrite-dependent damage ([@B45]). Whether this protective effect of the labile iron pool is translatable to other cell types and to neurons in particular, remains to be established.

Iron Dyshomeostasis in Neurodegeneration
========================================

Increased iron levels and the associated ROS generation are important initiators and mediators of cell death ([@B52]), whereas iron dyshomeostasis has a key role in neurodegeneration. Mutations of genes encoding proteins involved in iron homeostasis are associated with degeneration of central nervous system (CNS) cells ([@B171]; [@B235]), while oxidative stress induces cell injury by disrupting cellular iron balance ([@B35]; [@B101]), thus leading to a vicious circle. Both AD and PD entail increased brain iron content and oxidative stress ([@B43]; [@B219]; [@B212]; [@B74]), with the implied threat of hydroxyl radical-induced neuronal damage. Of note, binding of Cu or Fe to Aβ peptides generates H~2~O~2~ ([@B89]), which may induce neuronal oxidative stress during AD progression ([@B44]). Moreover, iron overload increases neuronal amyloid-β production and enhances cognitive impairment in a transgenic mice model of AD ([@B11]) while accumulating evidence suggests that impaired iron homeostasis is an early event in AD progression ([@B168]).

Parkinson's disease is a progressive neurodegenerative disease characterized by rigidity, tremor, and slowness of movement as well as by a wide range of debilitating non-motor symptoms. A key feature of PD is the selective loss of the dopaminergic neurons of the substantia nigra; ample evidence shows iron accumulation in these neurons ([@B92]; [@B235]; [@B13]; [@B140]; [@B2]). The observation that pharmacological agents with iron chelation capacity prevent neuronal death in AD or PD experimental models (recently reviewed in [@B150]) highlights the pivotal role of iron as a mediator of neuronal death in AD and PD.

In addition, spinal neurons from ALS patients display increased iron and calcium levels ([@B99]). The success of iron chelation therapy in ALS mouse models sustains the central role of iron in ALS pathogenesis ([@B94]; [@B106]). Alterations of proteins involved in iron metabolism, inhibition of anterograde axonal transport leading to iron accumulation in ventral motor neurons, and increased mitochondrial iron load in neurons and glia have been proposed as pathogenic mechanisms to explain the abnormal iron accumulation displayed by the neurons and glia of ALS mice ([@B94]).

Iron Dyshomeostasis in Inflammation
===================================

Inflammation, a condition often found in neurodegenerative environments, is yet another factor that induces iron accumulation (reviewed in [@B214]). Both the p50 and the p65 subunits of the transcription factor NF-κB bind to a NFκB-responsive element present in the 5′ untranslated region of the DMT1-1B promoter, inducing the expression of the 1B isoforms of DMT1 ([@B159],[@B160]). The transcription factor NF-κB is often activated by inflammatory signals ([@B182]; [@B79]; [@B189]). Accordingly, the possible association between inflammation and iron accumulation has been recently explored ([@B165]; [@B213], [@B214]; [@B128]). To this purpose, the effects of lipopolysaccharide (LPS) and the pro-inflammatory cytokines TNF-α and IL-6 on mRNA and protein levels of DMT1, FPN1, and hepcidin were investigated in astrocytes, microglia, and neurons isolated from rat brain. A causal association between inflammation and iron accumulation was reported, since in addition to increasing neuronal iron content, treatment with LPS, TNF-α, or IL-6 increases DMT1 expression and protein levels in neurons ([@B213]). Similar results were reported in studies of ventral mesencephalic neurons in primary culture, in which treatment with TNF-α or IL-1β induces an increment in DMT1 and TfR1 protein levels, together with a reduction of FPN1 levels ([@B216]). Considering that NFκB activation is downstream of the TNF-α, IL-1, and LPS signaling pathways, these results are consistent with a circuit in which inflammatory stimuli induce DMT1 expression and iron accumulation via NFκB activation and hepcidin expression.

An additional link between inflammation and increased oxidative stress resides in the observation that inflammatory stimuli activate the NADPH oxidase (NOX) enzyme, the main regulated source of cellular ROS generation ([@B70]; [@B214]; [@B197]). In particular, pro-inflammatory cytokines activate the phagocytic NOX2 enzyme, which is highly expressed in microglia ([@B196]; [@B116]; [@B9]). In turn, NOX2 activation generates an oxidative extracellular environment that increases ROS levels in neighboring neurons ([@B186]; [@B60]; [@B202]; [@B236]).

Of note, NOX activation has also been reported in experimental models of PD and AD. In particular treatment with MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), a prodrug to the Parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP+), results in increased synthesis of the pro-inflammatory cytokine IL-1β, and increased membrane translocation of the cytosolic NOX sub-unit p67^phox^, which is prevented by minocycline, a tetracycline derivative that exerts multiple anti-inflammatory effects ([@B224]). In addition, iron supplementation to midbrain neuron-glia cell cultures causes the selective death of dopaminergic neurons. This death is mediated by microglial NOX2 since cells derived from NOX2-/- mice do not present iron-induced neuronal death ([@B236]). Similarly, brain tissue from AD patients reveals an elevation in NOX activity coupled to membrane translocation of cytosolic NOX2 subunits and increased NOX1 and NOX3 mRNA transcripts ([@B190]; [@B4]). Significantly, the authors found an inverse correlation between postmortem NOX activity and ante-mortem cognitive status ([@B4]). Altogether, these results indicate that inflammatory stimuli generate a neuronal phenotype of increased iron influx and increased NOX-produced ROS, with the consequent risk of oxidative damage observed in neurodegenerative diseases.

Role of Iron in Excitotoxicity
==============================

Earlier reports indicate that iron plays a role in excitotoxicity, a death process mediated by high levels of intracellular calcium caused by excessive activity of excitatory neurotransmitters. Seminal observations by Cheah and colaborators described a signaling cascade in which stimulation of *N*-methyl-[D]{.smallcaps}-aspartate (NMDA) receptors activates the small GTPase Dexras1 via S-nitrosylation, mediated by activation of neuronal nitric oxide synthase (nNOS). Activated Dexras binds to the peripheral benzodiazepine receptor-associated protein PAP7, which in turn binds to the iron transporter DMT1 ([@B37]). Most importantly, treatment with neurotoxic concentrations of NMDA elicits a major increase in iron uptake, resulting in three- to fivefold increase of hydroxyl radical levels and the death of more than 90% of cells, whereas co-treatment with NMDA and a cell-permeant iron chelator largely blocked NMDA-induced cell death. Overall, these results indicate that glutamate-NMDA excitotoxicity elicits DMT1 activation and iron-mediated cell death ([@B37]). Although the role of calcium was not explored, the authors hypothesized initial calcium entrance through the NMDA receptor may activate nNOS, thus initiating this neurodegenerative process. As discussed below, crosstalk between NMDA receptor-mediated calcium influx and iron is likely to have a relevant role in neurodegenerative diseases such as AD and PD.

Neuronal Calcium Homeostasis and Signaling
==========================================

Calcium is a universal second messenger that regulates numerous cellular processes over a wide temporal range ([@B15]). In neurons, the free calcium concentration at rest lies in the 70--100 nM range ([@B40]), whereas extracellular calcium concentration is ∼1.5 mM. This large concentration gradient, combined with resting potential values of 70--90 mV (negative inside), generate a significant electrochemical gradient that favors calcium entry. Calcium homeostasis and signaling are vital for cellular function and survival; thus, neuronal cells possess powerful systems to maintain calcium homeostatic and signaling systems ([@B14]; [@B26]), which regulate the neuronal processes underlying synaptic plasticity and complex brain cognitive functions, such as information processing, learning, and memory. Calcium is stored also in intracellular organelles such as the endoplasmic reticulum (ER), where its free concentration lies in the 0.5 mM range. The main systems in charge of maintaining calcium homeostasis are two plasma membrane calcium (PMCA) transporters, the PMCA pump and the sodium/calcium exchanger (NCX), plus the sarco/ER Ca^2+^-ATPase (SERCA) pump that maintains the steep concentration gradient between the ER and the cytoplasm ([@B26]). These transporters utilize different mechanisms and display a range of calcium affinities, transport rates, and capacities to ensure the proper managing of the variety of intracellular increases in free calcium concentration, known as calcium signals, generated by the diverse stimuli neuronal cells receive.

Neuronal activity generates calcium signals that via sequential activation of calcium-dependent signaling cascades and transcription factors promote the expression of genes underlying dendritic development, synaptic plasticity, and neuronal survival ([@B26]). In response to neuronal stimulation, calcium influx through plasma membrane pathways, including agonist-operated, store-operated, or voltage-gated calcium channels (VGCCs), generates neuronal calcium signals. In addition, the release of calcium from intracellular stores such as the ER also contributes to neuronal calcium signal generation ([@B26]). All neuronal compartments crucial for neurotransmission have the two types of calcium release channels: the inositol 1,4,5-trisphosphate (IP~3~) receptor (IP~3~R) and the ryanodine receptor (RyR) channels ([@B14]). These large channels have complex gating and regulation and mediate a cellular process known as calcium-induced calcium release (CICR), whereby calcium promotes its own release from intracellular calcium stores ([@B14]). This CICR mechanism likely contributes to propagate calcium signals that reach distant targets such as the nucleus ([@B14]), where calcium promotes short or long-lasting changes in neuronal function and structure ([@B8]).

ROS Levels Influence Calcium Homeostasis and Signaling
======================================================

Significant evidence gathered in the last years indicates that increased cellular ROS levels modify the function of key proteins engaged in calcium homeostasis and signaling ([@B68]; [@B86]; [@B69]). Redox-dependent regulation of components that maintain neuronal Ca^2+^ homeostasis may influence the direction and/or the efficiency of Ca^2+^-signaling pathways. Interactions among ROS and calcium-dependent signaling pathways are bidirectional; while ROS regulate cellular calcium signaling, calcium signals are essential for ROS production because a number of ROS-generating and antioxidant systems of living cells are calcium-dependent ([@B68]).

Reversible modifications of proteins via ROS-promoted oxidation of their amino acids modify the properties of neuronal proteins engaged in signal transduction, such as protein kinases, protein phosphatases, and transcription factors ([@B218]). An increase in cellular ROS levels results in the inhibition of NMDA receptor function and in decreased activity of both the PMCA and the SERCA calcium pumps, while it enhances the activity of IP~3~R and RyR calcium channels ([@B86]; [@B97]). Consequently, ROS generation in neuronal cells increases cellular calcium levels by promoting calcium release mediated by IP~3~R and RyR channels and by inhibiting both the PMCA and the SERCA pumps: the ROS-mediated increase in calcium levels promotes changes in several calcium-dependent neuronal pathways ([@B230]; [@B179]). Depending on the magnitude of the calcium increase, activation of kinases or phosphatases implicated in synaptic plasticity process will occur (reviewed in [@B84]). In addition, activation of the large-conductance Ca^2+^-activated K^+^ (BKCa) by oxidation of SH cysteine residues, by decreasing neuronal excitability reduces the vulnerability of hippocampal neurons to hypoxia ([@B82]).

Defective Calcium Homeostasis and Signaling in Neurodegeneration
================================================================

A link between excessive intracellular calcium accumulation and neuronal death is by now firmly established ([@B47]; [@B199]; [@B58]). Neuronal cells are particularly sensitive to calcium-mediated cytotoxic damage and the failure of neurons to maintain Ca^2+^ homeostasis is a common feature of aged-linked neurodegenerative pathologies ([@B16]; [@B27]; [@B162]; [@B201]). Calcium dyshomeostasis ([@B162]) and altered neuronal calcium signaling ([@B36]; [@B156]) have been reported in a number of disease conditions, including AD, PD, and ALS (for recent reviews, see [@B56]; [@B172]; [@B173]; [@B194]). Likewise, defective calcium signaling in glia and autophagy-related pathways has been implicated in neurodegenerative disease ([@B145]). Accruing evidence implicates decreased levels and functional decline of PMCA isoforms in neurodegeneration ([@B76]; [@B201]). In addition, in many pathological conditions, disruptions of ER Ca^2+^ signaling disrupt neuronal function and promote neuronal cell death ([@B154]). To date, however, the detailed mechanisms of how neuronal Ca^2+^ homeostasis and signaling are perturbed in neurodegenerative diseases are not well understood.

The most common neurodegenerative disorder and the leading cause of dementia in the elderly is AD, whereas PD is the most prevalent age-associated movement disorder that entails early and selective degeneration of dopaminergic neurons. The pathological hallmarks of AD are neuronal loss and the presence of amyloid plaques and neurofibrillary tangles in the brain of affected individuals. Yet, before the emergence of plaques and/or neurofibrillary tangles other defects, including Ca^2+^ and iron dyshomeostasis, mitochondrial dysfunction, increased contacts between the ER and the mitochondria, neuro-inflammation, and alterations in lipid metabolism have been reported ([@B127]; [@B5]; [@B108]). How these early defects relate to the emergence and progression of AD remains to be established. Of note, a recent report by the [@B1] analyzed how defective calcium signaling may be an early upstream event in AD progression, and how alterations of the many cellular components that control calcium hemostasis and signaling leads to the decline in the function of more vulnerable neuronal cells. In particular, these more vulnerable neuronal cells present early synaptic dysfunction, upregulation of some calcium signaling related genes and significant decreases in the expression of genes related to synaptic neurotransmission, neurotrophic factor activity, mitochondrial metabolism, and energy production, among others ([@B1]).

In PD, dopaminergic neurons of the substantia nigra are especially vulnerable to Ca^2+^ dyshomeostasis, because their autonomous pace-making activity, through which these neurons generate action potentials in the absence of synaptic input ([@B75]). This particular property of dopaminergic neurons imposes a high pressure on adequate handling of activity-generated Ca^2+^ signals, presumably mediated by the significant calcium influx through plasma membrane L-type calcium channels that markedly surpasses the calcium influx displayed by other neurons ([@B204]).

Dopaminergic neurons are highly vulnerable to oxidants and mitochondrial inhibition compared to other neuronal types ([@B188]; [@B77]; [@B31]). Thus, brain permeant toxins such as rotenone, an inhibitor of NADH dehydrogenase, exclusively affect dopaminergic neurons ([@B188]; [@B34]). This special vulnerability is likely to produce the mitochondrial Ca^2+^ imbalance that occurs in PD ([@B120]). As discussed below, iron-induced ROS increases result in calcium signal generation, which may contribute to the basal calcium burden of dopaminergic neurons.

Several studies have reported defective Ca^2+^ signaling in other neurodegenerative conditions such as ALS ([@B193]; [@B71]; [@B91]; [@B137]) and multiple sclerosis (MS; [@B67]). The death of motor neuron is a characteristic feature of ALS. Excitotoxicity, which involves glutamate and calcium overload, or cell death caused by high levels of intracellular calcium caused by excessive activity of excitatory neurotransmitters, may contribute to ALS pathology. Calcium dysregulation is also present in MS, where the associated disability results from neuronal and axonal loss initiated by microglia activation and mediated by oxidative stress, excitotoxicity, calcium dysregulation, and mitochondrial dysfunction, leading to proteolytic enzyme production and apoptosis ([@B67]).

Additionally, calcium dysregulation has been associated with neuroinflammation, a CNS response that comprises biochemical and cellular responses to injury, infection, or neurodegenerative diseases ([@B50]). Neuroinflammation markers increase in some neurodegenerative conditions; microglia, the innate CNS immune cells, play key roles as mediators of these neuroinflammatory responses. Of note, Ca^2+^ and neuroinflammatory signaling mechanisms exhibit extensive crosstalk and bidirectional interactions. As an example, chronic brain inflammation leads to a feedback reduction in NMDA receptors caused by excess synaptic glutamate activity during microglial activation ([@B181]).

Despite the abundant literature that points to defective calcium homeostasis and signaling in neurodegeneration, scarce information is available in the literature regarding the protective effects of calcium modulators in preventing these defects. Yet, all recent reports on this subject highlight the fact that this is an urgent task. The non-competitive NMDA receptor antagonist Memantine, which reduces excitoxicity by inhibiting neuronal calcium entry ([@B17]), has been the most common drug for treating moderate to severe AD; nevertheless, Memantine provides only limited benefits for AD patients. A recent report showed that immunotherapy with a murine analog of the anti-Aβ antibody Aducanumab restores calcium homeostasis in a transgenic AD mice model ([@B100]), whereas a recent review addresses the evidence linking neurodegeneration to RyR dysfunction and describes novel therapeutic approaches to target abnormal RyR function ([@B107]). There are no reports, however, on the efficacy of these strategies for treating AD patients.

The HIF-1--Calcium Relationship
===============================

In SH-SY5Y neuroblastoma cells, chelation of calcium by 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) induces HIF-1α protein accumulation and nuclear localization, whereas the cytosolic calcium elevation produced by inhibition of the SERCA pump attenuates these effects ([@B12]). Further experiments indicated that calcium chelation attenuates the interaction of HIF-1α with the von-Hippel-Lindau protein, thus decreasing the proteasomal degradation of HIF-1α ([@B12]). Control experiments indicated that BAPTA did not complex intracellular iron ions, thus the above effects were caused by calcium chelation and not by stimulation of iron-activated PHD enzymes ([@B12]). Subsequent studies showed that intermittent hypoxia causes HIF-1α accumulation through a mechanism that involves increased cell calcium and increased generation of ROS by NOX, which induces a complex signaling pathway that results in increased HIF-1α synthesis and decreased hydroxylase-dependent HIF-1α degradation ([@B232]).

Although brain levels of HIF-1α are considered neuroprotective ([@B102]; [@B191]; [@B72]; [@B111]; [@B131]), under certain conditions, HIF-1α acts as a pro-apoptotic factor ([@B170]; [@B237]; [@B131]). For example, the anesthetic isoflurane induces apoptotic neurodegeneration in a process mediated by HIF-1α, since knockdown of HIF-1α expression attenuates isoflurane-induced neurotoxicity ([@B96]). In addition, isoflurane induces a significant elevation of cytoplasmic calcium levels in cultured neurons. Based on previous observations, showing that calcium mediates HIF-1α expression ([@B231]; [@B177]), the authors hypothesized that the high calcium levels induced by isofluorane promote HIF-1α-mediated apoptotic neurodegeneration. Studies discerning the calcium concentrations and other cell physiological condition, which elicit each of the above responses, should shed light on these apparent contradictory responses.

Overall, the emerging picture from the above results is consistent with the idea that low calcium concentrations stabilize HIF-1α protein levels by decreasing its proteasomal degradation. The effect of calcium concentrations above homeostatic levels is not clear and may depend on cell type: high calcium levels may induce a protective response consisting in increased HIF-1α synthesis coupled to decreased degradation or may mediate HIF-1α degradation.

Iron Modifies Neuronal Calcium Homeostasis and Calcium Signaling Pathways
=========================================================================

Iron overload increases intracellular calcium levels, which in turn activate calcineurin ([@B109]), a calcium-dependent phosphatase which has a key role in synaptic plasticity and memory processes ([@B10]). Increases in cytoplasmic calcium levels via the NMDA receptor stimulate the neuronal NOS enzyme ([@B62]) and generate superoxide anion in hippocampal neurons ([@B25]), while in cortical neurons, this calcium increase induces a signaling cascade that enhances superoxide generation through NOX activation ([@B66]).

Both synaptic plasticity and memory processes require activity-dependent hippocampal ROS generation ([@B18]; [@B98]; [@B104]). In primary hippocampal neurons, the ROS increase induced by iron promotes calcium release from the ER mediated by redox-sensitive RyR channels; the resulting increase in intracellular calcium levels link NMDA receptor stimulation to ERK1/2 activation and nuclear translocation ([@B138]). Since several reports indicate that CREB-dependent transcription of synaptic plasticity related genes entails ERK1/2-mediated long-term CREB phosphorylation ([@B226]; [@B121]; [@B209]). Accordingly, these findings indicate that iron-induced, RyR-mediated, calcium release contributes to this activity-dependent neuronal response.

In summary, the current evidence suggests that crosstalk between ROS and calcium plays an essential role in many pathophysiological conditions including neurodegenerative diseases such as PD and AD. Here we complement this idea by adding the component of iron overload, and the ensuing oxidative stress, as a significant factor in promoting calcium dysregulation in neurodegeneration.

The Synergism Between Iron and Calcium in Lipid Peroxidation
============================================================

A link between iron-mediated lipid peroxidation and calcium dyshomeostasis was reported more than 30 years ago. Peroxidation of rat brain synaptosomes by Fe^2+^ and H~2~O~2~ generates rapid and large uptake of Ca^2+^ by isolated synaptosomes; Fe^2+^ also enhances Ca^2+^ uptake by spinal cord neurons in culture, an effect that is coupled to lipid peroxidation and the release of arachidonic acid from cells, in a process prevented by the iron chelator DFO ([@B24]). The authors concluded that Fe^2+^ and Ca^2+^ act synergistically to produce lipid peroxidation and damage to neuronal membranes ([@B24]). A further report proposed that this is not a direct effect of calcium but the result of independently initiated processes of lipid peroxidation and Ca^2+^ translocation, which interact subsequently in a synergistic manner ([@B20]).

The relationship between iron-induced lipid peroxidation and dysregulation of Ca^2+^-ATPase is long-dated ([@B164]; [@B126]; [@B233]). Plasma membrane lipid peroxidation initiated by the Fenton reaction results in increased calcium content, derived from the inhibition of the plasma membrane and ER Ca^2+^-ATPases ([@B166]). This inhibitory effect is shared by other radical species, in particular by peroxynitrite ([@B234]). Oxidants also inhibit SERCA activity while promoting calcium release from the ER ([@B68]; [@B86]). Arguably, the observed upsurge in intracellular Ca^+2^ induced by iron-mediated lipid peroxidation could be compounded by an oxidant-induced loss of PMCA and SERCA activity, which combined with ROS-mediated activation of IP~3~R/RyR channels would result in further and deleterious increases in the intracellular Ca^2+^ concentration.

Iron, Calcium, and HIF-1 Activity
=================================

Considering the overlapping effects of iron and calcium on HIF-1 activity detailed above, a Fe/Ca bipartisan regulation of HIF-1 can be hypothesized ([Figure 1](#F1){ref-type="fig"}). In neurodegenerative diseases with an iron accumulation component, decreased HIF-1 activity is predicted by a mechanism that involves the maintenance of maximal HIF-1 hydrolase activities and the increase of intracellular calcium mediated by dysregulation of redox-sensitive calcium homeostatic and signaling pathways. In neurons, decreased HIF-1 activity results in decreased neuroprotective, neuroregenerative, and antioxidant responses associated to HIF-1 activity (see above).

![Regulation of HIF-1 activity by iron and calcium. HIF-1 activity is induced by hypoxia, which decreases the activity of HIF-1 hydrolases (PHD), by low iron (e.g., iron chelation), which also decreases the activity of HIF-1 hydrolases, and by low intracellular calcium, which decreases the interaction of HIF-1α with the von-Hippel-Lindau protein (see text). High intracellular calcium levels increase the rate of HIF-1 proteasomal degradation while high levels of iron both maintain the activity of HIF-1 hydrolases and, through enhanced ROS production increase the cellular levels of calcium by activation of RyR, IP~3~R, and L-type calcium channels.](fnins-13-00048-g001){#F1}

![Neuronal pathways that increase calcium and iron levels. Increases in ROS due to mitochondrial dysfunction, inflammation, and NOX activation promote excessive ROS generation that promotes calcium release via RyR channels and increases redox-active iron by IRP1 activation. Through the Fenton reaction, iron induces lipid peroxidation that inhibits the PMCA calcium pump. In addition, excitotoxic conditions over-activate NMDA receptors (NMDAR), which results in increased cytoplasmic calcium levels and increases iron levels via DMT1 activation.](fnins-13-00048-g002){#F2}

Calcium-Induced Iron Dyshomeostasis: Possible Role in Neurodegeneration
=======================================================================

Excessive intracellular calcium levels, such as those associated with neurodegenerative conditions, are likely to produce high H~2~O~2~ levels via NOX2 and to enhance mitochondrial calcium uptake and ROS production. These two ROS sources, NOX2, and mitochondria should affect jointly iron homeostasis by increasing the cellular labile iron pool, as occurs in SH-SY5Y cells exposed to H~2~O~2~ ([@B48]). These findings raise the possibility that conditions that increase postsynaptic calcium levels following NMDA receptor activation, which promote H~2~O~2~ generation in neocortical neurons via a cascade engaging the NOS and NOX2 enzymes ([@B66]), may lead to an upsurge of the labile iron pool.

The role of voltage-gated Ca^2+^ channels as mediators of iron transport into neuronal cells is well established ([@B59]; [@B117]). Another link between iron and calcium during neurodegeneration was provided by the observation that the hippocampal and nigral neuron loss induced by intra-cerebroventricular FeCl~3~ injection in rats is largely prevented by pre-treatment with nicardipine, a blocker of L-type VGCCs ([@B22]). The authors concluded that these channels mediate the neurotoxic effects of extracellular iron by inducing either calcium and/or iron uptake. The question remains as to whether the protective effect of nicardipine is due to decreased iron influx, decreased calcium influx, or to a calcium-mediated process leading to neurodegeneration downstream of iron-induced oxidative stress. Other studies have also provided evidence of iron influx through NMDA receptors or voltage-operated calcium channels in primary hippocampal neurons ([@B163]) and the dopaminergic MES23.5 cell line ([@B217]).

The Mitochondrion Melting POT: Calcium, Iron, and Apoptotic Cell Death
======================================================================

Mitochondria, by taking up and releasing calcium, act as important regulators of cellular calcium levels. The large mitochondrial membrane potential difference (negative inside) provides the driving force for calcium entry through the mitochondrial calcium uniporter (MCU), a component of the inner mitochondrial membrane; in physiological conditions, calcium antiporters rapidly extrude calcium from the mitochondria and restore the basal calcium levels ([@B65]). Mitochondrial calcium concentration modulates ATP production and mitochondrial metabolism, whereas mitochondrial calcium overload induced by deregulated intracellular calcium levels promotes apoptotic cell death, necrosis, and autophagy ([@B64]; [@B178]; [@B123]). In pathological conditions, the MCU has been implicated in excitotoxicity, iron overload, inflammation, and oxidative stress-induced mitochondrial dysfunction and cell death ([@B115]). The ROS generated by mitochondrial enzymes or the electron transport chain presumably regulate diverse cellular physiological pathways, whereas dysregulated ROS generation may contribute to the development of human diseases ([@B3]).

Neurodegenerative disorders such as AD, PD, and ALS display dysregulation of calcium homeostasis and mitochondrial dysfunction; in addition, excitotoxicity leads to mitochondrial calcium overload and promotes necrotic or apoptotic-like excitotoxic cell death ([@B81]; [@B180]; [@B21]; [@B63]; [@B65]). An increase in mitochondrial calcium is of particular importance in dopaminergic neurons, which are constantly exposed to calcium influx ([@B205]). The interaction between calcium overload and excessive ROS production ([@B38]) causes further damage to the electron transport chain and promotes oxidative stress, which induces the oxidation of mitochondrial lipids, proteins, and DNA leading to cytotoxicity ([@B141]). The vicious cycle between calcium overload and oxidative stress favors the sustained opening of the mitochondrial permeability transition pore (mPTP), leading to the collapse of the mitochondrial membrane potential and mitochondrial swelling, which in turn promote the apoptotic response ([@B49]). Opening of the mPTP has a central role in the pathogenesis of neurodegenerative disorders ([@B215]; [@B167]).

Excessive iron levels promote oxidative stress leading to the upsurge of unrestrained calcium signals that damage mitochondrial function. Iron accumulation in the cytoplasm induces excessive iron influx into mitochondria through mitoferrin1/2 ([@B161]), which causes mitochondrial dysfunction by increased ROS production leading to oxidative damage. Hence, if uncontrolled, this calcium/iron self-feeding cycle becomes deleterious to mitochondrial and neuronal function, leading eventually to neuronal death. In this regard, it is of note that, by preserving mitochondrial calcium homeostasis, the iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration ([@B183]).

In primary hippocampal neurons, iron-induced stimulation of redox-sensitive RyR-mediated calcium release causes significant mitochondrial fragmentation ([@B185]). Iron overload induces oxidative stress in the ER earlier than in the mitochondria, thereby increasing ER stress and calcium levels, and consequently causing mitochondrial fragmentation and neuronal cell death ([@B109]). Mitochondrial fragmentation presumably contributes to the impairment of neuronal function produced by iron overload, since inhibition of mitochondrial division protects neuronal cells from excitotoxicity ([@B184]). Moreover, iron overload of HT-22 hippocampal neuron cells increases intracellular calcium levels, causes mitochondrial fragmentation via dephosphorylation of Drp1, and increases apoptotic neuronal death; of note, calcium chelation and inhibition of calcineurin prevented mitochondrial fragmentation and cell death ([@B109]). Based on these findings, the authors suggested that calcium-mediated calcineurin signaling, by regulating mitochondrial dynamics, has a key role in iron-induced neurotoxicity.

In summary, mitochondrial calcium overload combined with excessive iron-mediated ROS generation and mPTP opening compose a cell death-inducing sequence implicated in neuronal dysfunction and neurodegeneration.

Oxytosis/Ferroptosis a Possible Meeting Point for Calcium and Iron-Induced Cell Death
=====================================================================================

Oxytosis was first described as a glutamate-induced, calcium-dependent form of cell death ([@B142]). Initial studies on the molecular mechanisms of oxytosis pointed to a decrease in intracellular glutathione levels, enhanced mitochondrial ROS production, lipid peroxidation, and massive calcium influx as causes of death ([@B132]). The mechanistic link between glutamate exposure and glutathione depletion was the inhibition of the cysteine/glutamate antiporter xc- by glutamate, which deprived cells of cystine, a precursor in glutamate synthesis ([@B143]). As glutathione levels decrease, ROS levels increase exponentially ([@B207]), which gives rise to the activation of signaling pathways that culminate in large influx of calcium and cell death ([@B122]). Thus, the increased calcium influx is an essential mediator of the cell death program, as cells do not die in calcium-free medium.

Ferroptosis is a form of regulated cell death that occurs because of lethal lipid peroxidation. Ferroptotic cell death is blocked by iron chelators, lipophilic antioxidants, and by agents that block propagation of lipid peroxidation ([@B200]; [@B57]). Ferroptosis is induced by inhibition of the cystine-glutamate antiporter xc- or by inhibition of glutathione peroxidase 4 (Gpx4). Induction of ferroptosis by erastin (an inhibitor of the antiporter xc-) results in cell death, which is morphologically characterized by mitochondrial shrinkage, with no overt signs of apoptosis or necrosis ([@B51]). Ferroptotic death derives from depletion of cell glutathione, increased oxidative stress, and iron-mediated lipid peroxidation to lethal levels ([@B200]). Inhibition of Gpx4 also causes ferroptosis ([@B228]). Gpx4 is a lipid peroxidase that directly reduces phospholipid hydroperoxides at the expense of reduced glutathione. In mice, conditional deletion in forebrain neurons of Gpx4 resulted in hippocampal neurodegeneration and behavior dysfunction, associated with markers of ferroptosis such as elevated lipid peroxidation, ERK1/2 activation, and neuroinflammation ([@B78]). Given the large similarity in their cell death mechanisms, the current view is that oxytosis and ferroptosis are similar forms of cell death ([@B57]; [@B113]; [@B122]).

Although a lethal influx of calcium is an intrinsic feature of oxytosis, the participation of calcium in ferroptosis is still poorly defined. Initial work by [@B51] revealed that calcium chelators do not inhibit erastin-induced HT-1080 cell death. Nevertheless, as mentioned above, an increase in cellular ROS levels enhances the activity of IP~3~R and RyR calcium release channels and decreases the activity of both the PMCA and the SERCA calcium pumps. These effects increase cellular calcium levels by promoting calcium release from the ER while inhibiting its removal by the calcium pumps.

Lipid peroxidation-derived modification of some calcium channels could also be intermediates in ferroptotic death ([@B122]). In particular, 4-hydroxynonenal, a product of hydroxyl radical-mediated lipid peroxidation, induces the opening of NMDA receptor and VGCCs ([@B119]). Indeed, the store-operated calcium entry (SOCE) system, which activates calcium influx channels in the plasma membrane upon the release of intracellular calcium from the ER participates in the neuronal death induced by MPP+, a Parkinsonian toxin that inhibits mitochondria electron transport chain complex I. Inhibition of the SOCE response decreased apoptotic cell death, reduced ROS production, and decreased lipid peroxidation induced by MPP+ ([@B114]). In the same vein, a recent report shows that the pharmacological or transcriptional inhibition of SOCE proteins protects against oxidative glutamate toxicity and against MPP+ injury ([@B122]).

Overall, these results point to a possible participation of calcium in ferroptosis, a participation driven by raises in cytoplasmic calcium because of oxidative- and lipid peroxidation-derived modifications of the calcium homeostasis machinery ([Figure 3](#F3){ref-type="fig"}). This participation may be specific to cells with weak antioxidant defenses, which could allow for the oxidative activation of calcium channels.

![Iron and calcium-mediated cell death by ferroptosis. Increases in ROS due to mitochondrial dysfunction, non-physiological activation of NOX, excitotoxicity, inflammation, or other factors result in the increase of redox-active iron mediated by activation of IRP1. Through the Fenton reaction, iron induces lipid peroxidation that activates NMDAR and the SOCE system, which results in increased cytoplasmic calcium. Increased iron levels and lipid peroxidation mediate ferroptotic cell death, which may also be induced by unregulated calcium levels. Increased ROS levels decrease the intracellular GSH content, leading to ferroptosis, and activate the intracellular calcium channels RyR and IP3R, which adds to the increase in cytoplasmic calcium caused by iron-induced lipid peroxidation.](fnins-13-00048-g003){#F3}

Protection of Iron Overload by Nrf2; the Calcium Connection
===========================================================

Under oxidative stress conditions, the transcription factor known as nuclear factor (erythroid-derived 2)-like 2 (Nrf2) directs the expression of a large array of cytoprotective genes ([@B210]). In particular, Nrf2 protects cells from the injurious effects of iron overload by regulating the expression of genes involved in iron storage and iron export ([@B39]; [@B101]). These findings raise the possibility that Nrf2 may counteract the oxidative stress induced in neuronal cells by iron overload. Thus, Nrf2 may restore the intracellular labile iron pool by inducing the expression of the iron exporter FPN1 and ferritin, which oxidizes Fe^2+^ to Fe^3+^ and stores it within its structure making it unavailable for the Fenton reaction ([@B155]). In addition, intracellular iron levels act as a link between HIF-1α and Nrf2: Nrf2-induced ferritin upregulation activates HIF-1α by making iron unavailable to HIF prolyl-hydroxylase ([@B192]), whereas Nrf2 inhibition results in decreased activation of HIF-1α by hypoxia ([@B103]; [@B95]).

Recent studies point to a connection between ROS, cellular calcium signals, and Nrf2. The neurotrophin BDNF, besides inducing complex neuronal signaling cascades underlying synaptic plasticity ([@B19]), also induces neuronal antioxidant responses through BDNF-induced Nrf2 nuclear translocation ([@B23]; [@B29]). In this regard, a recent study showed that BDNF-mediated activation of Nrf2 in astrocytes, which is under circadian control, protects dopaminergic neurons from ferroptosis ([@B90]). Of note, in primary hippocampal neurons, ROS and RyR-mediated calcium signals are required for BDNF-induced nuclear translocation of Nrf2 ([@B29]). It remains to be established if iron overload in hippocampal neurons engages BDNF and RyR-mediated calcium signals to promote Nrf2-induced expression of protective genes.

Conclusion
==========

This article reviews the little acknowledged relationship between iron and calcium in neurodegeneration. The main premise of this article is that increased ROS production generated by iron accumulation profoundly influences calcium homeostasis and signaling ([Figure 4](#F4){ref-type="fig"}).

![The self-feeding cycle ROS--Fe--Ca. Mitochondrial dysfunction promotes in increased ROS and activation IRP1, which results in increased iron accumulation. Excess iron promotes lipid peroxidation by hydroxyl radicals derived from the Fenton reaction. Lipid peroxidation modifies the activity of a variety of proteins involved in calcium homeostasis that results in massive calcium influx. Increased cytoplasmic calcium levels result in increased mitochondrial calcium and accentuated mitochondrial dysfunction, oxidative stress, and damage. If uncontrolled, this ROS--iron--calcium self-feeding cycle becomes deleterious to mitochondrial and neuronal function, leading eventually to apoptotic or ferroptotic cell death. In yet another aspect of this cycle, high intracellular calcium levels increase the rate of HIF-1 proteasome degradation, which results in increased ROS levels, product of decreased expression of antioxidant proteins.](fnins-13-00048-g004){#F4}

The influence of increased ROS is clearly shown in the process of oxytosis, in which lipid peroxidation initiated by Fenton-derived hydroxyl radicals results in the modification of a variety of proteins involved in calcium homeostasis that brings to calcium upsurges and cell death. Increased cytoplasmic calcium levels caused by iron dysregulation result in increased mitochondrial calcium and accentuated oxidative stress and damage. If uncontrolled, this calcium/iron self-feeding cycle becomes deleterious to mitochondrial and neuronal function, leading eventually to neuronal death. In yet another aspect of neurodegeneration, high intracellular calcium levels increase the rate of HIF-1 proteasomal degradation while high levels of iron both maintain the activity of HIF-1 hydrolases and, through oxidative stress increase the cellular levels of calcium by activation of ER and PMCA channels. The main conclusion we draw from this review is that dysregulated iron or calcium levels promote deleterious crosstalk between iron and calcium that can result in neuronal dysfunction and death. To our knowledge, this is the first attempt in literature to systemize this important relationship.

Author Contributions
====================

MN and CH wrote this article.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** This work was supported by FONDEF project 17I10095 from the National Commission of Science and Technology (CONICYT) of Chile; Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT; Grants Nos. 1170053 and 11140580), and by Biomedical Neuroscience Institute (Grant No. BNI P09-015-F).

[^1]: Edited by: Giorgio Biasiotto, Università degli Studi di Brescia, Italy

[^2]: Reviewed by: Veronica Perez de la Cruz, Instituto Nacional de Neurología y Neurocirugía (INNN), Mexico; Nicola B. Mercuri, University of Rome Tor Vergata, Italy

[^3]: This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience
